CHEK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Although the ATM-Chk2-p53 pathway seems to be activated in CML and protects CP-CML cells from progression to BC, some additional key components of the DDR machinery, such as the BRCA1 tumor suppressor, are downregulated in CML [48,49].